Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1985 May;19(5):685–692. doi: 10.1111/j.1365-2125.1985.tb02696.x

Specific antagonism of adenosine-induced bronchoconstriction in asthma by oral theophylline.

J S Mann, S T Holgate
PMCID: PMC1463831  PMID: 4005106

Abstract

The airway response to increasing concentrations of inhaled-adenosine and histamine after oral theophylline or matched placebo was studied in nine asthmatic subjects. Changes in airway calibre were followed as sGaw and FEV1 and concentration-response curves constructed. Inhaled adenosine caused concentration-related bronchoconstriction and was four-five times less potent than inhaled histamine. Theophylline, which achieved a mean plasma level of 15.9 and 16.6 micrograms/ml on the histamine and adenosine study days respectively, caused significant increases in FEV1 (17%) and sGaw (41-53%) whereas placebo had no effect. Theophylline also protected the airways against histamine-and adenosine-induced bronchoconstriction. However theophylline had a greater protective effect against adenosine (concentration-ratio 17.4 for FEV1 and 12.8 for sGaw) than against histamine (concentration ratio 5.6 for FEV1 and 5.4 for sGaw (P less than 0.05]. At therapeutic concentrations theophylline is a specific antagonist of the airway effects of adenosine in addition to being a bronchodilator and a functional antagonist.

Full text

PDF
688

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arch J. R., Newsholme E. A. The control of the metabolism and the hormonal role of adenosine. Essays Biochem. 1978;14:82–123. [PubMed] [Google Scholar]
  2. BUTCHER R. W., SUTHERLAND E. W. Adenosine 3',5'-phosphate in biological materials. I. Purification and properties of cyclic 3',5'-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3',5'-phosphate in human urine. J Biol Chem. 1962 Apr;237:1244–1250. [PubMed] [Google Scholar]
  3. Bandouvakis J., Cartier A., Roberts R., Ryan G., Hargreave F. E. The effect of ipratropium and fenoterol on methacholine-histamine-induced bronchoconstriction. Br J Dis Chest. 1981 Jul;75(3):295–305. doi: 10.1016/0007-0971(81)90009-7. [DOI] [PubMed] [Google Scholar]
  4. Bergstrand H. Phosphodiesterase inhibition and theophylline. Eur J Respir Dis Suppl. 1980;109:37–44. [PubMed] [Google Scholar]
  5. Billing B., Dahlqvist R., Garle M., Hörnblad Y., Ripe E. Separate and combined use of terbutaline and theophylline in asthmatics. Effects related to plasma levels. Eur J Respir Dis. 1982 Sep;63(5):399–409. [PubMed] [Google Scholar]
  6. Chung K. F., Morgan B., Keyes S. J., Snashall P. D. Histamine dose-response relationships in normal and asthmatic subjects. The importance of starting airway caliber. Am Rev Respir Dis. 1982 Nov;126(5):849–854. doi: 10.1164/arrd.1982.126.5.849. [DOI] [PubMed] [Google Scholar]
  7. Cushley M. J., Tattersfield A. E., Holgate S. T. Adenosine antagonism as an alternative mechanism of action of methylxanthines in asthma. Agents Actions Suppl. 1983;13:109–113. [PubMed] [Google Scholar]
  8. Cushley M. J., Tattersfield A. E., Holgate S. T. Adenosine-induced bronchoconstriction in asthma. Antagonism by inhaled theophylline. Am Rev Respir Dis. 1984 Mar;129(3):380–384. doi: 10.1164/arrd.1984.129.3.380. [DOI] [PubMed] [Google Scholar]
  9. Cushley M. J., Tattersfield A. E., Holgate S. T. Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects. Br J Clin Pharmacol. 1983 Feb;15(2):161–165. doi: 10.1111/j.1365-2125.1983.tb01481.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fredholm B. B., Brodin K., Strandberg K. On the mechanism of relaxation of tracheal muscle by theophylline and other cyclic nucleotide phosphodiesterase inhibitors. Acta Pharmacol Toxicol (Copenh) 1979 Nov;45(5):336–344. doi: 10.1111/j.1600-0773.1979.tb02402.x. [DOI] [PubMed] [Google Scholar]
  11. Fredholm B. B. Release of adenosine from rat lung by antigen and compound 48/80. Acta Physiol Scand. 1981 Apr;111(4):507–508. doi: 10.1111/j.1748-1716.1981.tb06772.x. [DOI] [PubMed] [Google Scholar]
  12. Fredholm B. B. Theophylline actions on adenosine receptors. Eur J Respir Dis Suppl. 1980;109:29–36. [PubMed] [Google Scholar]
  13. Higbee M. D., Kumar M., Galant S. P. Stimulation of endogenous catecholamine release by theophylline: a proposed additional mechanism of action for theophylline effects. J Allergy Clin Immunol. 1982 Nov;70(5):377–382. doi: 10.1016/0091-6749(82)90028-8. [DOI] [PubMed] [Google Scholar]
  14. James H. C., Gamlen T. R., Batstone G. F. An appraisal of a fluoro-immuno assay technique for the determination of blood theophylline concentration. Ann Clin Biochem. 1983 Jul;20(Pt 4):251–252. doi: 10.1177/000456328302000413. [DOI] [PubMed] [Google Scholar]
  15. Mackay A. D., Baldwin C. J., Tattersfield A. E. Action of intravenously administered aminophylline on normal airways. Am Rev Respir Dis. 1983 May;127(5):609–613. doi: 10.1164/arrd.1983.127.5.609. [DOI] [PubMed] [Google Scholar]
  16. Marquardt D. L., Gruber H. E., Wasserman S. I. Adenosine release from stimulated mast cells. Proc Natl Acad Sci U S A. 1984 Oct;81(19):6192–6196. doi: 10.1073/pnas.81.19.6192. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Mentzer R. M., Jr, Rubio R., Berne R. M. Release of adenosine by hypoxic canine lung tissue and its possible role in pulmonary circulation. Am J Physiol. 1975 Dec;229(6):1625–1631. doi: 10.1152/ajplegacy.1975.229.6.1625. [DOI] [PubMed] [Google Scholar]
  18. Olsson O. A., Persson C. G. Effect of beta-adrenoceptor stimulators, papaverine and theophylline on guinea-pig trachea contracted by different drugs. Acta Pharmacol Toxicol (Copenh) 1976 Mar;38(3):281–283. doi: 10.1111/j.1600-0773.1976.tb03121.x. [DOI] [PubMed] [Google Scholar]
  19. Orehek J., Charpin D., Velardocchio J. M., Grimaud C. Bronchomotor effect of bronchoconstriction-induced deep inspirations in asthmatics. Am Rev Respir Dis. 1980 Feb;121(2):297–305. doi: 10.1164/arrd.1980.121.2.297. [DOI] [PubMed] [Google Scholar]
  20. Salome C. M., Schoeffel R. E., Yan K., Woolcock A. J. Effect of aerosol fenoterol on the severity of bronchial hyperreactivity in patients with asthma. Thorax. 1983 Nov;38(11):854–858. doi: 10.1136/thx.38.11.854. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Svedmyr K., Mellstrand T., Svedmyr N. A comparison between effects of aminophylline, proxyphylline and terbutaline in asthmatics. Scand J Respir Dis Suppl. 1977;101:139–146. [PubMed] [Google Scholar]
  22. Thompson P. J., Kemp M. W., McAllister W., Turner-Warwick M. The use of aminophylline by inhalation. Br J Clin Pharmacol. 1982 Sep;14(3):463–464. doi: 10.1111/j.1365-2125.1982.tb02011.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Triner L., Vulliemoz Y., Verosky M. Cyclic 3',5'-adenosine monophosphate and bronchial tone. Eur J Pharmacol. 1977 Jan 7;41(1):37–46. doi: 10.1016/0014-2999(77)90368-5. [DOI] [PubMed] [Google Scholar]
  24. Weinberger M. The pharmacology and therapeutic use of theophylline. J Allergy Clin Immunol. 1984 May;73(5 Pt 1):525–540. doi: 10.1016/0091-6749(84)90505-0. [DOI] [PubMed] [Google Scholar]
  25. Wolff J., Londos C., Cooper D. M. Adenosine receptors and the regulation of adenylate cyclase. Adv Cyclic Nucleotide Res. 1981;14:199–214. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES